← Back to KNSA

Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSMar 2026Filed 28/04/2026Sep 2025Filed 28/10/2025Jun 2025Filed 28/10/2025Mar 2025Filed 28/04/2026Sep 2024Filed 28/10/2025Jun 2024Filed 28/10/2025Mar 2024Filed 28/10/2025Sep 2023Filed 29/10/2024
$214$181$157$138$112$109$80$67
$23$18$18$8.5−$13−$3.9−$18−$14
$0.27$0.23$0.23$0.11−$0.18−$0.06−$0.25−$0.20
8280787672717170

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.